Table 4.
ASM index, prevalence of radiographic knee OA, knee pain and both radiographic and knee pain of the women with history of HRT use.
| Duration of HRT use < 1 year (N = 240) | Duration of HRT use ≥ 1 year (N = 398) | p-value | |||
|---|---|---|---|---|---|
| Mean or row percent | Standard error | Mean or row percent | Standard error | ||
| ASM index (%, mean) | 24.47 | 0.20 | 24.80 | 0.16 | 0.181 |
| Sarcopenia (proportion) | 0.147 | ||||
| No | 30.20 | 4.02 | 37.89 | 3.24 | |
| Yes | 69.80 | 4.02 | 62.11 | 3.24 | |
| Radiographic knee OA (proportion) | 0.689 | ||||
| No | 62.27 | 4.36 | 64.47 | 3.28 | |
| Yes | 37.73 | 4.36 | 35.53 | 3.28 | |
| Knee pain (proportion) | 0.634 | ||||
| No | 75.23 | 4.11 | 77.73 | 3.38 | |
| Yes | 24.77 | 4.11 | 22.27 | 3.38 | |
| Radiographic knee OA & knee pain (proportion) | 0.649 | ||||
| No | 86.84 | 3.30 | 88.64 | 2.14 | |
| Yes | 13.16 | 3.30 | 11.36 | 2.14 | |
Radiographic knee OA, Kellgren–Lawrence grade scale grade ≥ 2; knee pain, knee pain for 30 days over the past 3 months.
Continuous variables were analyzed by one-way ANOVA and categorical variables were analyzed by Rao-Scott Chi-square test.
OA osteoarthritis, ASM appendicular skeletal muscle mass, Wt body weight, HRT hormone replacement therapy.